Mesa Laboratories Inc (MLAB) is a publicly traded Technology sector company. As of October 13, 2026, MLAB trades at $127.88 with a market cap of $713.53M and a P/E ratio of 153.69. MLAB moved +0.73% today. Year to date, MLAB is +63.15%; over the trailing twelve months it is +89.09%. Its 52-week range spans $55.45 to $152.03. Rallies surfaces MLAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Mesa Labs launches restructuring plan to cut annualized operating costs by about $9.3 million: Mesa Laboratories launched a plan targeting about $9.3 million in annualized operating cost cuts, with about $4.3 million reinvested for growth and a net annualized reduction of about $5 million. The plan includes eliminating about 40 roles and exiting its Hamburg facility when its lease ends in February 2027.
| Metric | Value |
|---|---|
| Price | $127.88 |
| Market Cap | $713.53M |
| P/E Ratio | 153.69 |
| EPS | $0.86 |
| Dividend Yield | 0.16% |
| 52-Week High | $152.03 |
| 52-Week Low | $55.45 |
| Volume | 35.89K |
| Avg Volume | 0 |
| Revenue (TTM) | $249.72M |
| Net Income | $4.80M |
| Gross Margin | 64.21% |
MLAB analyst coverage data. Average price target: $0.00.